Neurocrine Biosciences Inc.

(NBIX) Trade

By |

Profile

Neurocrine Biosciences Inc engages in the discovery and development of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States.

Contact Information

Website: www.neurocrine.com
Email: ir@neurocrine.com
Main Phone: +1 858 617-7600
Address: 12780 El Camino Real
State: CA
City / Town: San Diego
Country: USA
Postal Code: 92130

Issuer Information

Exchange: NGS
CEO: Kevin C. Gorman
Employees: 440
NAICS: Biological Product (except Diagnostic) Manufacturing (325414)
$ 103.90 $ 0.47 (0.45%)
Last Price 103.90 Change $ 0.47 Change % 0.45 Tick N/A
Bid 103.83 Bid Size 300.00 Ask 103.96 Ask Size 300.00
Open 103.53 High 105.36 Low 103.14 Prev Close 103.43
Last Trade Volume 262,670 52 Wk Hi 106.26 52 Wk Low 46.72
Market Cap 9.3 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 89,897,863.00 EPS (TTM) -1.20 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 13 103
Number of Buys 5 35
Number of Sells 8 68
Net Activity 27377 -27712
Last 10 Buys Shares
Mark N. Lampert 1,000
Mark N. Lampert 1,000
Mark N. Lampert 1,000
Mark N. Lampert 1,000
Mark N. Lampert 1,000
Mark N. Lampert 1,000
Mark N. Lampert 1,000
W. Thomas Mitchell 1,000
Last 10 Sell Shares
Stephen A. Sherwin 1,000
Eric S. Benevich 1,000
Corinne H. Nevinny 1,000
Kevin C. Gorman 1,000
Darin Lippoldt 1,000
Kyle Gano 1,000
Haig P. Bozigian 1,000
Haig P. Bozigian 1,000
Gary A. Lyons 1,000
Dimitri E. Grigoriadis 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 139 139 139 139
Low Target Price Estimate 85 85 85 85
Mean Target Price Estimate 106 106 106.33 106
Standard Deviation 13.86 13.86 13.99 13.86
Date of Most Recent Estimate 05/29/18 05/29/18 05/14/18 05/29/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 10 10 11 11
Moderate Buy 1 1 1 1
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.09 1.09 1.08 1.08